Adaltis extends HIV test range with Calypte deal:
This article was originally published in Clinica
Canadian company Adaltis is to sell Alameda, California-based Calypte Biomedical's serum HIV-1 Western Blot test under a worldwide, non-exclusive agreement. The private Montreal-based company already sells HIV tests, but has not had a Western Blot supplementary test until now.
You may also be interested in...
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”
The Onyx One Clear study, evaluating the Resolute Onyx drug-eluting stent in high bleeding risk patients, met its primary endpoint at the one-year follow up.